Received Jan 1, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
and am a paraplegic as a result; This serious case was reported by a consumer via interactive digital media and described the occurrence of paraplegia in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced paraplegia (Verbatim: and am a paraplegic as a result) (serious criteria GSK medically significant). The outcome of the paraplegia was not reported. It was unknown if the reporter considered the paraplegia to be related to Shingrix. The company considered the paraplegia to be unrelated to Shingrix. Additional Information: GSK receipt date: 29-DEC-2025 This case was reported by a patient via interactive digital media. The patient reported that I got a Shingrix vaccine six years ago and am a paraplegic as a result. The patient reports I am not anti-vax, but be advised of possible side-effects. GSK, while their attorneys admit causality for patient paralysis and have been fighting my attorney ever since. I'd rather have gotten shingles. The batch number was not provided, and we are unable to contact the reporter.; Sender's Comments: A case of Paraplegia, an unknown time after receiving Shingrix, in a patient. Causal association is indeterminate. Based on the available information,?a?possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.